Strategies that increase adiponectin, including weight reduction, exercise, and thiazolidinediones in diabetic patients, may counteract the adipokine imbalance associated with obesity-related cancer risk. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.